Patents by Inventor Hans Berg

Hans Berg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230097342
    Abstract: The present invention relates to a cryoprotecting agent comprising a cryprotectant being one or more of: dextrin, dextran, isomaltooligosaccharide and derivatives thereof, cryoprotecting and cryopreserved compositions, uses thereof, and methods of cryopreservation.
    Type: Application
    Filed: September 20, 2022
    Publication date: March 30, 2023
    Inventors: Hans Berg ANDREASEN, Lars CHRISTENSEN, Kim NORDFJELD, Jeppe SKYTTE, Christian CLAUSEN, Bjorn HOLST
  • Patent number: 11484025
    Abstract: The present invention relates to a cryoprotecting agent comprising a cryprotectant being one or more of: dextrin, dextran, isomaltooligosaccharide and derivatives thereof, cryoprotecting and cryopreserved compositions, uses thereof, and methods of cryopreservation.
    Type: Grant
    Filed: November 29, 2013
    Date of Patent: November 1, 2022
    Assignee: PHARMACOSMOS HOLDING A/S
    Inventors: Hans Berg Andreasen, Lars Christensen, Kim Nordfjeld, Jeppe Skytte, Christian Clausen, Bjorn Holst
  • Publication number: 20150320031
    Abstract: The present invention relates to a cryoprotecting agent comprising a cryprotectant being one or more of: dextrin, dextran, isomaltooligosaccharide and derivatives thereof, cryoprotecting and cryopreserved compositions, uses thereof, and methods of cryopreservation.
    Type: Application
    Filed: November 29, 2013
    Publication date: November 12, 2015
    Applicant: PHARMACOSMOS A/S
    Inventors: Hans Berg ANDREASEN, Lars CHRISTENSEN, Kim NORDFJELD, Jeppe SKYTTE, Christian CLAUSEN, Björn HOLST
  • Patent number: 8728828
    Abstract: The present invention relates to a separation matrix comprised of porous particles to which antibody-binding protein ligands have been immobilized, wherein the ligand density is in the range of 5.0-10 mg/ml; the gel phase distribution coefficient of the particles expressed as Kav for a dextran of size 110 kDa is above 0.65 and the median particle diameter is between 65-84 ?m. The carbohydrate material is preferably highly cross-linked agarose.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: May 20, 2014
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Hans Berg, Hans Johansson, Gunnar Malmquist, Per-Mikael Aberg
  • Patent number: 8309709
    Abstract: The present invention relates to a method of preparing an insoluble separation matrix, which method comprises salt-treatment of a polysaccharide gel followed by cross-linking of the polysaccharide polymers. In one embodiment, the method comprises providing an aqueous solution of a gelatable native polysaccharide; lowering the temperature of the polysaccharide solution to a value below its gelling point; salt-treatment by adding at least one salt to the resulting polysaccharide; and cross-linking the salt-treated polysaccharide. The polysaccharide may be prepared e.g. into particles, membranes or monoliths.
    Type: Grant
    Filed: June 28, 2006
    Date of Patent: November 13, 2012
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Hans Berg, Maria Brannholm, David Buckley, Philippe Busson, Anders Hagvall, Eva Holmgren, Henrik Ihre, Anders Larsson, Dag Lindstrom
  • Publication number: 20100136647
    Abstract: The present invention relates to the field of adherent cell culture. More closely, the invention relates to a method for production of a cell attachment and culture surface, such as a microcarrier, comprising a guanidino-containing ligand, wherein the ligand is coupled via reaction involving a primary amine to the surface which is activated by activation groups such that the final molar ratio of grafted ligand and ungrafted activation groups is above 1.5. Preferably, the ligand density is above 0.5 mmol/g cell culture surface and the remaining activation groups after coupling is less than 0.6 mmol/g cell culture surface. The cell culture surface may be used for various purposes, primarily cell cultivation and virus production.
    Type: Application
    Filed: November 23, 2009
    Publication date: June 3, 2010
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Mattias Algotsson, Hans Berg, Asa Bjurling, Christian Kaisermayer, Bjorn Noren, Nicholas Thevenin, James Van Alstine
  • Patent number: 7396467
    Abstract: The present invention relates to a method of preparing a porous cross-linked polysaccharide chromatography matrix, which comprises to provide an aqueous solution of a gellable polysaccharide, wherein part of the hydroxyl groups are substituted with groups which are not susceptible to nucleophilic attack; to provide essentially spherical droplets of the substituted polysaccharide solution; to form a gel of the substituted polysaccharide solution; and to cross-link the gel by adding a cross-linking agent. The invention also encompasses a chromatography column packed with a matrix so produced as well as use thereof in e.g. protein purification.
    Type: Grant
    Filed: October 13, 2004
    Date of Patent: July 8, 2008
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Hans Berg, David Buckley, Maria Brännholm, Anders Hagvall, Henrik Ihre, Eva Holmgren, Anders Larsson, Dag Lindstrom
  • Publication number: 20080154031
    Abstract: The present invention relates to a method of preparing an insoluble separation matrix, which method comprises salt-treatment of a polysaccharide gel followed by cross-linking of the polysaccharide polymers. In one embodiment, the method comprises providing an aqueous solution of a gelatable native polysaccharide; lowering the temperature of the polysaccharide solution to a value below its gelling point; salt-treatment by adding at least one salt to the resulting polysaccharide; and cross-linking the salt-treated polysaccharide. The polysaccharide may be prepared e.g. into particles, membranes or monoliths.
    Type: Application
    Filed: June 28, 2006
    Publication date: June 26, 2008
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Hans Berg, Maria Brannholm, David Buckley, Philippe Busson, Anders Hagvall, Eva Holmgren, Henrik Ihre, Anders Larsson, Dag Lindstrom
  • Patent number: 7341682
    Abstract: The present invention is a process of manufacture of one or more polysaccharide beads, comprising generating an aerosol of an aqueous polysaccharide solution, cooling the droplets of said aerosol in air to initiate gelling thereof and collecting droplets as gelled beads in a liquid or on a surface, characterised by adding a hydrophilic vapour pressure-lowering agent to said polysaccharide solution.
    Type: Grant
    Filed: April 17, 2003
    Date of Patent: March 11, 2008
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Ralf Göran Andersson, Hans Berg, Ingemar Jonsson, Anders Larsson
  • Patent number: 7208093
    Abstract: The present invention is a method of producing a chromatographic separation matrix, wherein porous polymeric particles comprised of two layers with different properties are prepared in a two-phase system by (a) providing porous polymeric particles with reactive groups on their surfaces; (b) washing said particles with a first solvent and draining the particles to enclose a first phase; (c) wetting the outer layer of the particles by adding a second solvent, which is essentially insoluble in the first solvent; (d) reacting the reactive groups in the outer layer by adding a reagent, which is essentially non-reactive in the first solvent; and (e) coupling of chromatographic binding groups to the reactive groups in the inner layer. The invention also encompasses a porous polymer particle suitable for use as a chromatographic separation matrix and a process of separation, wherein a matrix according to the invention is used.
    Type: Grant
    Filed: August 18, 2003
    Date of Patent: April 24, 2007
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Hans Berg, Philippe Busson, Mats Carlsson
  • Publication number: 20060252152
    Abstract: The present invention relates to a microcarrier onto the surface of which a cationic compound has been immobilised via a guanidine group. The microcarrier is capable of attachment of cells, e.g. via charge-based interaction, and is advantageously used as a support in the culture of cells. Said compound may comprise one or two amino acids, such as arginine (Arg) or a dipeptide. The invention also relates to a method of preparing a polycationic microcarrier, which method comprises to immobilise a compound that comprises at least one guanidine group to an epoxide-activated substrate.
    Type: Application
    Filed: October 5, 2004
    Publication date: November 9, 2006
    Inventors: James Alstine, Hans Berg, Asa Bjurling
  • Patent number: 7074335
    Abstract: The present invention is a method of producing porous beads, which comprises the steps of providing a first liquid phase comprising a bead matrix material and essentially edgy templating particle(s), said particle(s) being treated with a surface modifying agent; providing a second liquid phase which is immiscible with the first liquid phase; contacting the first phase and the second phase under conditions resulting in an emulsion of droplets comprised of the first liquid phase dispersed in the continuous second liquid phase; transforming the droplets to mesoporous beads by solidification of the liquid; and removing the templating particle(s) from the beads without causing any essential change of the surrounding bead, whereby hierarchical networks of pores are provided in the beads.
    Type: Grant
    Filed: December 17, 2002
    Date of Patent: July 11, 2006
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Hans Berg, Mats Carlsson, Anders Larsson
  • Publication number: 20060134805
    Abstract: The present invention relates to a separation matrix comprised of porous particles to which antibody-binding protein ligands have been immobilised, wherein the ligand density is in the range of 5.0-10 mg/ml; the gel phase distribution coefficient of the particles expressed as Kav for a dextran of size 110 kDa is above 0.65 and the median particle diameter is between 65-84 ?m. The carbohydrate material is preferably highly cross-linked agarose.
    Type: Application
    Filed: December 22, 2005
    Publication date: June 22, 2006
    Inventors: Hans Berg, Gunnar Malmquist, Per-Mikael Aberg, Hans Johansson
  • Publication number: 20060060534
    Abstract: The present invention relates to a method of preparing a porous cross-linked polysaccharide chromatography matrix, which comprises to provide an aqueous solution of a gellable polysaccharide, wherein part of the hydroxyl groups are substituted with groups which are not susceptible to nucleophilic attack; to provide essentially spherical droplets of the substituted polysaccharide solution; to form a gel of the substituted polysaccharide solution; and to cross-link the gel by adding a cross-linking agent. The invention also encompasses a chromatography column packed with a matrix so produced as well as use thereof in e.g. protein purification.
    Type: Application
    Filed: October 13, 2004
    Publication date: March 23, 2006
    Inventors: Hans Berg, David Buckley, Maria Brannholm, Anders Hagvall, Henrik Ihre, Eva Holmgren, Anders Larsson, Dag Lindstrom
  • Patent number: 7000296
    Abstract: In order to lease threads (F), in particular warp threads into guide elements (2) of a handling device (1), such as combs or reeds, the threads (F) are first leased in sequence into a leasing comb (11) and are fixed thereto. The threads (F) are subsequently guided through the device (1) by means of the leasing comb (11). During this process, the threads (F) are taken up by the guide elements (2).
    Type: Grant
    Filed: June 15, 2000
    Date of Patent: February 21, 2006
    Inventors: Hans Berg, Heinrich Johann Mensing, Wolfgang Lange
  • Publication number: 20060025585
    Abstract: A method for the manufacture of a solid porous separation material based on a polysaccharide, said method comprising the steps of: (a) providing an aqueous solution (I) of a polysaccharide, (b) solidifying the solution, preferably by transforming the solution to a gel, and (c) optionally cross-linking the polysaccharide, with the proviso that, if step (c) is present, steps (b) and (c) may be carried out simultaneously. The method is characterised in that the polysaccharide provided in step (a) is modified by being inter-molecularly cross-linked to an extent such that the viscosity of solution (I) is at least 110%, preferably at least 200%, of the viscosity of an aqueous solution (II) of the corresponding polysaccharide which has not been inter-molecularly cross-linked and which is present in the same concentration as the inter-molecularly cross-linked polysaccharide is in solution (I).
    Type: Application
    Filed: September 12, 2005
    Publication date: February 2, 2006
    Inventors: Hans Berg, Mats Carlsson
  • Patent number: 6984733
    Abstract: A method for the manufacture of a solid porous separation material based on a polysaccharide, said method comprising the steps of: (a) providing an aqueous solution (I) of a polysaccharide, (b) solidifying the solution, preferably by transforming the solution to a gel, and (c) optionally crosslinking the polysaccharide, with the proviso that, if step (c) is present, steps (b) and (c) may be carried out simultaneously.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: January 10, 2006
    Assignee: Amersham Biosciences AB
    Inventors: Hans Berg, Mats Carlsson
  • Patent number: 6977249
    Abstract: In a process for producing an iron-dextran compound for use in parenteral treatment of iron-deficiency in humans or animals a stable compound of desired relatively low molecular weight is obtained by using first hydrogenation and then oxidation to convert reducing terminal groups on the dextran molecules before reaction with the iron. By varying the ratio of hydrogenated groups to oxygenated groups the average molecular weight of the resulting iron-dextran compound can be varied.
    Type: Grant
    Filed: July 29, 1999
    Date of Patent: December 20, 2005
    Assignee: Pharmacosmos Holding A/S
    Inventors: Hans Berg Andreasen, Lars Christensen
  • Publication number: 20050242037
    Abstract: The present invention is a method of producing a chromatographic separation matrix, wherein porous polymeric particles comprised of two layers with different properties are prepared in a two-phase system by (a) providing porous polymeric particles with reactive groups on their surfaces; (b) washing said particles with a first solvent and draining the particles to enclose a first phase; (c) wetting the outer layer of the particles by adding a second solvent, which is essentially insoluble in the first solvent; (d) reacting the reactive groups in the outer layer by adding a reagent, which is essentially non-reactive in the first solvent; and (e) coupling of chromatographic binding groups to the reactive groups in the inner layer. The invention also encompasses a porous polymer particle suitable for use as a chromatographic separation matrix and a process of separation, wherein a matrix according to the invention is used.
    Type: Application
    Filed: August 18, 2003
    Publication date: November 3, 2005
    Inventors: Hans Berg, Philippe Busson, Mats Carlsson
  • Publication number: 20050179151
    Abstract: The present invention is a process of manufacture of one or more polysaccharide beads, comprising generating an aerosol of an aqueous polysaccharide solution, cooling the droplets of said aerosol in air to initiate gelling thereof and collecting droplets as gelled beads in a liquid or on a surface, characterised by adding a hydrophilic vapour pressure-lowering agent to said polysaccharide solution.
    Type: Application
    Filed: April 17, 2003
    Publication date: August 18, 2005
    Inventors: Ralf Andersson, Hans Berg, Ingemar Jonsson, Anders Larsson